Related Experiment Video
Updated: Sep 26, 2025

Spatial Multiobjective Optimization of Agricultural Conservation Practices using a SWAT Model and an Evolutionary Algorithm
Published on: December 9, 2012
Exploring an Efficient Evolutionary Game Model for the Government-Enterprise-Public during the Double Carbon Policy
Bilin Zou1, Chunhua Ju1,2, Fuguang Bao1,2,3
1School of Management and E-Business, Zhejiang Gongshang University, Hangzhou 310018, China.
Abstract:
The realization of China's "double carbon" goal is of great significance to the world environment and China's economy and society. Through the establishment of the "government-enterprise-public" evolutionary game model, this paper explores the interaction between government policy guidance, low-carbon technology R&D behavior of enterprises, and public purchase of carbon label products, as well as the micro-driving path, aiming to provide suggestions for the implementation of the "double carbon" policy and carbon label system in China. The results show that the choice of government, enterprises, and public strategies is closely related to their own costs and benefits. Public sentiment can effectively urge the government to actively fulfill its responsibilities. Effective government policy guidance plays a key role in low-carbon technology R&D behavior of enterprises. There is an interaction between low-carbon technology R&D behavior of enterprises and public purchase of carbon label products.
Related Concept Videos
Dynamic Equilibrium
Global Regulatory Systems
Mechanistic Models: Compartment Models in Individual and Population Analysis
Limits to Natural Selection
Energy Budgets
Parameters Affecting Nonlinear Elimination: Zero-Order Input, First-Order Absorption and Two-Compartment Model
When a drug is administered through a constant intravenous infusion and eliminated via nonlinear pharmacokinetics, it follows zero-order input. For example, oral drugs undergo first-order absorption upon administration and are eliminated through nonlinear pharmacokinetics.
In the case of subcutaneously administered drugs,...

